Alios BioPharma Signs Flu Treatment Deal with University of Hong Kong
October 31, 2011 -- Alios BioPharma of South San Francisco has licensed technology that targets influenza from Versitech Limited, the technology transfer arm of the University of Hong Kong. The technology may lead to novel medications that treat the flu through a “novel chemical matter that targets a unique component of the influenza virus life cycle.” More details....